Your session is about to expire
← Back to Search
Home Visiting for Child Development and Parenting
Study Summary
This trial will study the long-term impact of the CHI SJC program, which provides home-visiting services to families with young children, to determine its effectiveness in improving child development, school readiness, family economic self-sufficiency, maternal health, and other outcomes.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My child is older than 3 months.My child is 3 months old or younger.
- Group 1: Home Visiting Group
- Group 2: Business as Usual Group
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is there an age limit for participants in this research project?
"This medical trial involves participants aged between one and three months old."
Is there an opportunity to join the experiment now?
"As indicated on clinicaltrials.gov, this particular investigation is not currently looking for participants. The trial was originally established in October 2016 before being updated most recently in February of 2023; however, there are 180 other studies that presently have open recruitment slots available."
Who has been deemed eligible to partake in this investigation?
"343 neonates in the one-month to three-month range, with child development issues, are being recruited for this trial; they must be a firstborn child of either parent and live within the tri-county jurisdiction encompassing the research. Furthermore, participants must have been less than 3 months old at enrollment."
Share this study with friends
Copy Link
Messenger